Cytosorbents Corp.

Cytosorbents Corp.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
31.46 M
Public Float
29.65 M
Cytosorbents Corp.
Stock Exchange NASDAQ Stock Market
EPS
$0.61
Market Cap
$223.49 M
Shares Outstanding
32.25 M
Public Float
27.49 M

Profile

Address
7 Deer Park Drive
Monmouth Junction New Jersey 08852
United States
Employees -
Website http://cytosorbents.com
Updated 07/08/2019
CytoSorbents Corp. engages in the development of blood purification technology for the reduction of deadly uncontrolled inflammation in hospitalized patients. Its product, CytoSorb, is a extracorporeal cytokine filter and seeks to reduce cytokine storm that could otherwise cause massive inflammation, organ failure, and death in common critical illnesses such as sepsis, burn injury, trauma, lung injury, and pancreatitis. The company was founded by Joseph Rubin on April 25, 2002 and is headquartered in Monmouth Junction, NJ.

Financials

View All
Created with Highcharts 5.0.14Cytosorbents Corp.Net Income. Fiscal year is January-December. All values USD Thousands.4 6774 6779 3219 3218 1318 13111 76311 7638 4608 46017 21117 21120132014201520162017201805k10k15k20k
Created with Highcharts 5.0.14Cytosorbents Corp.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.2 4222 4224 1224 1224 7914 7919 5279 52715 15015 15022 50322 50320132014201520162017201805k10k15k20k25k

Phillip P. Chan
President Chief Executive Officer & Director
Al W. Kraus
Independent Non-Executive Chairman